Company / Tangible Book Value per Share
Intellia Therapeutics, Inc. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$6.58
FY2025
5-year range
$6.58 / $16.59
FY2021-FY2025
Trend
-29.8%
vs FY2024
Sector context
#68 of 163
Health Care
What the data says
At $6.58, Intellia Therapeutics, Inc.'s tangible book value per share ranks #68 of 163 in the Health Care sector. Tangible Book Value per Share has declined for 3 consecutive years, from $16.59 in FY2022 to $6.58 in FY2025.
Based on SEC 10-K filings.
6.58 in FY2025 with a 5-year CAGR of -8.9%.
Declined from $12.06 to $6.58 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -26.5%
- 5-Year CAGR
- -8.9%
- 10-Year CAGR
- -
Sector benchmark
#68 of 163 in Health CareTop 42% of 163This company $6.58 Sector average $18.18
▼
-63.8% below sector average
Key checks
Key Insights
- Intellia Therapeutics, Inc.'s tangible book value per share has declined for 3 consecutive years.
- In FY2025, tangible book value per share decreased 29.8% year-over-year.
- Ranks #68 out of 163 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.58 | -29.8% |
| FY2024 | $9.38 | -22.2% |
| FY2023 | $12.06 | -27.3% |
| FY2022 | $16.59 | +5.6% |
| FY2021 | $15.71 | +49.6% |
| FY2020 | $10.50 | +75.9% |
| FY2019 | $5.97 | -9.0% |
| FY2018 | $6.56 | -21.5% |
| FY2017 | $8.35 | -11.6% |
| FY2016 | $9.44 | +110.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026